August 23, 2019
Kalytera’s Cannabidiol Prevents Graft-Versus-Host-Disease After Bone Marrow Transplant, Data Show
News
Kalytera’s cannabidiol (CBD) compound efficiently prevents graft-versus-host disease (GVHD) in patients receiving bone marrow transplants from matched unrelated donors, interim ... Read more
August 21, 2019
CAR T-cell Therapy Combo Shows Promise in Treating Advanced Multiple Myeloma, Study Says
News
Using a combination of CAR T-cell therapies to target different cancer molecules appears to be a feasible and promising way of ... Read more
August 19, 2019
Risk of Multiple Myeloma in People with MGUS Can Rise Over Time, Study Finds
News
People with monoclonal gammopathy of undetermined significance (MGUS) placed at low- or intermediate-risk of progression to multiple myeloma can ... Read more
August 16, 2019
Evomela Approved as Pre-transplant Conditioning Therapy for Multiple Myeloma Patients in China
News
Evomela, an injectable formulation of melphalan, is now available in China as a high-dose conditioning therapy for people with multiple ... Read more
August 14, 2019
Triple Therapies Best, But Revlimid with Dexamethasone Could Work in Some Difficult-to-Treat Myelomas, Study Shows
News
Although triple therapies with Revlimid (lenalidomide) should be prioritized in patients with relapsed or refractory multiple myeloma (RRMM), combining ... Read more
August 12, 2019
‘Moving Mountains for Multiple Myeloma’ Takes Trek Challenge to Iceland
News
Aiming to both inspire the multiple myeloma community and raise money to accelerate treatments, members of Moving Mountains for Multiple Myeloma ... Read more
August 9, 2019
AJMC Introduces 14-part Video Series on Multiple Myeloma Treatment
News
A new video series by the American Journal of Managed Care (AJMC) features experts discussing issues related to multiple myeloma treatment. Called ... Read more
August 7, 2019
clonoSEQ Assay Approved in New York to Measure MRD in Myeloma, Other Blood Cancers
News
The clonoSEQ Assay — a test that detects cancer cells present in very small numbers in a patient’s bone marrow, ... Read more
August 5, 2019
First Patient Dosed in Phase 1 Trial of Antibody for Advanced Multiple Myeloma, Teneobio Announces
News
A Phase 1 trial evaluating Teneobio’s bispecific antibody TNB-383B as a treatment for multiple myeloma has started dosing patients. ... Read more
August 2, 2019August 2, 2019
Tally of Risk Factors Can Identify Myeloma Patients at Risk of Deep-vein Blood Clots, Study Suggests
News
A simple score of risk factors could help alert doctors to a likelihood of dangerous blood clots, called venous ... Read more
July 31, 2019
Donor-derived CAR T-cell Therapy ALLO-715 Enters Clinical Testing for Multiple Myeloma
News
Allogene Therapeutics is launching the first clinical trial testing ALLO-715, its “off-the-shelf” CAR T-cell therapy, for people with multiple ... Read more
July 29, 2019
CHMP Favors Empliciti Triple Combo to Treat Advanced Multiple Myeloma Patients in EU
News
The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), has recommended ... Read more

August 23, 2019

Kalytera’s Cannabidiol Prevents Graft-Versus-Host-Disease After Bone Marrow Transplant, Data Show

News

Kalytera’s cannabidiol (CBD) compound efficiently prevents graft-versus-host disease (GVHD) in patients receiving bone marrow transplants from matched unrelated donors, interim data from a Phase 2 study show. Considering the study’s ... Read more

August 21, 2019

CAR T-cell Therapy Combo Shows Promise in Treating Advanced Multiple Myeloma, Study Says

News

Using a combination of CAR T-cell therapies to target different cancer molecules appears to be a feasible and promising way of treating relapsed or refractory multiple myeloma, a study reports. The ... Read more

August 19, 2019

Risk of Multiple Myeloma in People with MGUS Can Rise Over Time, Study Finds

News

People with monoclonal gammopathy of undetermined significance (MGUS) placed at low- or intermediate-risk of progression to multiple myeloma can develop that cancer within five years, a study of blood ... Read more

August 16, 2019

Evomela Approved as Pre-transplant Conditioning Therapy for Multiple Myeloma Patients in China

News

Evomela, an injectable formulation of melphalan, is now available in China as a high-dose conditioning therapy for people with multiple myeloma who will undergo a stem cell transplant, CASI Pharmaceuticals, ... Read more

August 14, 2019

Triple Therapies Best, But Revlimid with Dexamethasone Could Work in Some Difficult-to-Treat Myelomas, Study Shows

News

Although triple therapies with Revlimid (lenalidomide) should be prioritized in patients with relapsed or refractory multiple myeloma (RRMM), combining this therapy with dexamethasone could be effective if the patients ... Read more

August 12, 2019

‘Moving Mountains for Multiple Myeloma’ Takes Trek Challenge to Iceland

News

Aiming to both inspire the multiple myeloma community and raise money to accelerate treatments, members of Moving Mountains for Multiple Myeloma (MM4MM) recently traversed Iceland’s impressive landscape. The 14-member excursion included ... Read more

August 9, 2019

AJMC Introduces 14-part Video Series on Multiple Myeloma Treatment

News

A new video series by the American Journal of Managed Care (AJMC) features experts discussing issues related to multiple myeloma treatment. Called “A Review of the Treatment for Multiple Myeloma,” the 14-part ... Read more

August 7, 2019

clonoSEQ Assay Approved in New York to Measure MRD in Myeloma, Other Blood Cancers

News

The clonoSEQ Assay — a test that detects cancer cells present in very small numbers in a patient’s bone marrow, blood, or tissue sample — now is available to New ... Read more

August 5, 2019

First Patient Dosed in Phase 1 Trial of Antibody for Advanced Multiple Myeloma, Teneobio Announces

News

A Phase 1 trial evaluating Teneobio’s bispecific antibody TNB-383B as a treatment for multiple myeloma has started dosing patients. This safety and tolerability trial is recruiting people with advanced ... Read more

August 2, 2019August 2, 2019

Tally of Risk Factors Can Identify Myeloma Patients at Risk of Deep-vein Blood Clots, Study Suggests

News

A simple score of risk factors could help alert doctors to a likelihood of dangerous blood clots, called venous thromboembolism, forming as a side effect of immunomodulatory therapies (IMiD) ... Read more